Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
WATCH NOWTrump's SCOTUS List, Football Is Back, & Laundry Problems | Pardon the DisruptionWatch Here

Press Release

FreedomWorks Statement in Response to Drug Pricing Executive Order

WASHINGTON, D.C.-- In response to President Trump announcing his signing of an executive order implementing an international pricing index (IPI) for pharmaceuticals with a most-favored-nation (MFN) provision, Adam Brandon, FreedomWorks President, commented:

“President Trump declared that ‘America will never be a socialist nation,’ yet this order will tie our healthcare system to a number of nations that have socialized medicine. We believe this order is a mistake and urge him to reconsider.

“The American healthcare system is one of the best in the world, and this order threatens to drastically reduce its quality for millions. It is true that Americans do pay more for access to care than most do globally. However, it is for this very reason that we encourage the administration to pursue real free-market solutions to this problem, rather than resorting to price controls.

“We hope the administration will reconsider, and we are ready, willing, and able to assist them with any free market healthcare proposals in the future.”